Interactions of the antibiotics neomycin B and chlortetracycline with the hammerhead ribozyme as studied by Zn2+-dependent RNA cleavage.
We have investigated the interactions of two antibiotics, neomycin B and chlortetracycline (CTC), with the hammerhead ribozyme using two Zn(2+) cleavage sites at U4 and A9 in its catalytic core. CTC-dependent inhibition of Zn(2+) cleavage was observed in all cases. In contrast, we unexpectedly observed acceleration of A9 cleavage by neomycin under low ionic strength conditions similar to those used to study inhibition of hammerhead substrate cleavage by this antibiotic. This result provides evidence that the inhibitory mechanism of neomycin does not include competition with the metal ion bound to the A9/G10.1 metal-ion binding site, as previously proposed. Under high ionic strength conditions, optimized for Zn(2+)-dependent cleavage, we observed neomycin-dependent inhibition of cleavage at both A9 and U4. The ability of neomycin to both inhibit and accelerate Zn(2+) cleavage suggests that there is either more than one neomycin binding site or multiple binding modes at a single site in the hammerhead ribozyme. Furthermore, the accessibilities and/or affinities of disparate neomycin binding sites or binding modes are dependent on the ionic strength and the pH of the medium.
Department of Chemistry, University of Washington, Seattle, WA 98195-1700, USA.
Emily J
EJ
Borda
Snorri Th
ST
Sigurdsson
D000900:Anti-Bacterial Agents / Q000494:pharmacology; D001665:Binding Sites; D002384:Catalysis; D002751:Chlortetracycline / Q000494:pharmacology*; D005601:Framycetin / Q000494:pharmacology*; D006863:Hydrogen-Ion Concentration; D009994:Osmolar Concentration; D012313:RNA / Q000378:metabolism*; D016337:RNA, Catalytic / Q000037:antagonists & inhibitors* / Q000378:metabolism; D015032:Zinc
D000900:Anti-Bacterial Agents; D016337:RNA, Catalytic; C427204:hammerhead ribozyme; D005601:Framycetin; D012313:RNA; D015032:Zinc; D002751:Chlortetracycline